FULC / Fulcrum Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Fulcrum Therapeutics, Inc.
US ˙ NasdaqGM ˙ US3596161097

Deler fremragende 54,091,588 shares
Insideraktier33.804.692 shares
Insider ejerskab62,50 %
Total Insiders43
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )

2143 out of 11308

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000 %( )

2125 out of 11226

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Fulcrum Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
6 Dimensions Capital, L.P. 10% Owner - [10%] 559.821 559.821
Santiago Arroyo Chief Medical Officer - [O] 0 0
Sonja Banks Director - [D] 0 0
Diego Cadavid SVP Clinical Development - [O] 65.714 65.714
Casdin Capital, LLC 10% Owner - [10%] 604.285 604.285
Eli Casdin 10% Owner - [10%] 604.285 604.285
Casdin Partners GP, LLC 10% Owner - [10%] 604.285 604.285
Casdin Partners Master Fund, L.P. 10% Owner - [10%] 604.285 604.285
Collins James J. Director - [D] 47.142 47.142
Katina Dorton Director - [D] 0 0
Judith Dunn See Remarks - [O] 0 0
Alan Ezekowitz Director - [D] 57.854 57.854
James A Geraghty Director - [D] 90.714 90.714
Plc Glaxosmithkline 10% Owner - [10%] 1.785.714 1.785.714
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Robert J Gould Interim President & CEO, Director - [D] [O] 499.864 499.864
Kate Haviland 9.285
Hayes Melvin H. III Chief Operating Officer - [O] 0 0
Colin Hill Director - [D] 0 0
Patrick Taylor Horn Chief Medical Officer - [O] 0 0
Mark J Levin Director, 10% Owner - [D] [10%] 3.962.202 3.962.202
William J Maris 10% Owner - [10%] 464.285 464.285
Christopher Morabito Chief Medical Officer - [O] 1.100 1.100
Christopher Moxham Chief Scientific Officer - [O] 0 0
Alan A Musso Chief Financial Officer - [O] 0 0
Curtis Gale Oltmans SVP, General Counsel - [O] 1.248 1.248
Ra Capital Management, Llc 10% Owner - [10%] 20.458.198 20.458.198
Esther Rajavelu Chief Financial Officer - [O] 0 0
Kevin P Starr 10% Owner - [10%] 3.962.202 3.962.202
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Sanofi 10% Owner - [10%] 558.035 558.035
Alex Sapir See Remarks, Director - [D] [O] 193.360 193.360
Section 32 Fund 2, LP 10% Owner - [10%] 464.285 464.285
Section 32 GP 2, LLC 10% Owner - [10%] 464.285 464.285
Bryan Stuart See Remarks, Director - [D] [O] 0 0
Robert I Tepper 10% Owner - [10%] 3.962.202 1.962.202
Trv Gp Iii, Llc 10% Owner - [10%] 3.962.202 1.962.202
Trv Gp Iv, Llc 10% Owner - [10%] 2.343.154 2.343.154
Third Rock Ventures GP III, L.P. 10% Owner - [10%] 3.962.202 1.962.202
Third Rock Ventures GP IV, L.P. 10% Owner - [10%] 2.343.154 2.343.154
Third Rock Ventures III, L.P. 10% Owner - [10%] 1.962.202 1.962.202
Third Rock Ventures IV, L.P. 10% Owner - [10%] 2.343.154 2.343.154
Thomson Peter G. VP Finance & Accounting - [O] 2.300 2.300
Greg Tourangeau Principal Accounting Officer - [O] 14.062 14.062
Wallace Owen B. Chief Scientific Officer - [O] 133.438 133.438

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i FULC / Fulcrum Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2024-03-04 Sapir Alex 43.360 11,3475 43.360 11,3475 492.028 2 12.0000 28.293 5,75
2023-01-20 RA CAPITAL MANAGEMENT, LLC 1.923.076 13,0000 1.923.076 13,0000 24.999.988
2023-01-04 RA CAPITAL MANAGEMENT, LLC 122.334 7,0276 122.334 7,0276 859.714
2023-01-04 RA CAPITAL MANAGEMENT, LLC 58.369 7,7968 58.369 7,7968 455.091
2022-12-27 RA CAPITAL MANAGEMENT, LLC 4.089 5,9941 4.089 5,9941 24.510
2022-12-19 RA CAPITAL MANAGEMENT, LLC 98.787 5,8997 98.787 5,8997 582.814
2022-12-16 RA CAPITAL MANAGEMENT, LLC 1.341.420 5,4195 1.341.420 5,4195 7.269.826
2022-12-15 RA CAPITAL MANAGEMENT, LLC 237.029 5,4950 237.029 5,4950 1.302.474
2022-12-14 RA CAPITAL MANAGEMENT, LLC 824.600 5,4591 824.600 5,4591 4.501.574

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FULC / Fulcrum Therapeutics, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i FULC / Fulcrum Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2025-05-08 Tourangeau Greg 498 5,0600 498 5,0600 2.520 1 5.3700 155 6,16
2024-05-07 Tourangeau Greg 236 7,7600 236 7,7600 1.831
2024-03-08 Tourangeau Greg 4.884 11,7155 4.884 11,7155 57.219
2023-05-10 Tourangeau Greg 210 3,3100 210 3,3100 695

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FULC / Fulcrum Therapeutics, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2025-05-09 2025-05-08 4 Tourangeau Greg FULC Common Stock S - Sale D 5,0600 -498 -3 14.062
2024-09-23 3 RA CAPITAL MANAGEMENT, LLC See footnotes FULC Common Stock I 10.229.099
2024-08-23 2024-08-21 4 RA CAPITAL MANAGEMENT, LLC See footnotes FULC Common Stock J - Other I -8.500.000 3.109.704
2024-07-08 2024-07-03 4 Sapir Alex FULC Common Stock M - Exercise D 3,2700 150.000 490 193.360
2024-06-18 3 Hill Colin FULC No securities are beneficially owned D 0
2024-05-09 2024-05-07 4 Tourangeau Greg FULC Common Stock S - Sale D 7,7600 -236 -2 11.571
2024-03-20 3 Horn Patrick Taylor FULC No securities are beneficially owned D 0
2024-03-08 2024-03-08 4 Tourangeau Greg FULC Common Stock S - Sale D 11,7155 -4.884 -57 11.807
2024-03-05 2024-03-04 4 Sapir Alex FULC Common Stock P - Purchase D 11,3475 43.360 492 43.360
2023-08-09 3 Musso Alan A FULC No securities are beneficially owned D 0
2023-05-11 2023-05-10 4 Tourangeau Greg FULC Common Stock S - Sale D 3,3100 -210 -1 15.992
2023-01-24 2023-01-20 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 13,0000 1.923.076 25.000 11.609.704
2023-01-13 2023-01-13 4 Gould Robert J FULC Common Stock S - Sale D 15,0000 -6.766 -101 499.864
2023-01-06 2023-01-04 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 7,7968 58.369 455 9.686.628
2023-01-06 2023-01-04 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 7,0276 122.334 860 9.628.259
2022-12-29 2022-12-27 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 5,9941 4.089 25 9.505.925
2022-12-21 2022-12-19 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 5,8997 98.787 583 9.501.836
2022-12-16 2022-12-16 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 5,4195 1.341.420 7.270 9.403.049
2022-12-16 2022-12-15 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 5,4950 237.029 1.302 8.061.629
2022-12-16 2022-12-14 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 5,4591 824.600 4.502 7.824.600
2022-12-15 2022-12-13 4 Third Rock Ventures III, L.P. FULC Common Stock J - Other D -2.000.000 1.962.202
2022-11-09 3 Arroyo Santiago FULC No securities are beneficially owned D 0
2022-08-26 3 Shah Rajeev M. FULC Common Stock I 7.000.000
2022-08-11 3 Hayes Melvin H. III FULC No securities are beneficially owned D 0
2022-06-08 2022-06-07 4 Gould Robert J FULC Common Stock S - Sale D 8,0898 -71.435 -578 506.630
2022-06-08 2022-06-07 4 Gould Robert J FULC Common Stock M - Exercise D 7,8400 71.435 560 578.065
2022-06-06 2022-06-06 4 Gould Robert J FULC Common Stock S - Sale D 8,1040 -24.382 -198 506.630
2022-06-06 2022-06-06 4 Gould Robert J FULC Common Stock M - Exercise D 7,8400 24.382 191 531.012
2022-06-06 2022-06-03 4 Gould Robert J FULC Common Stock S - Sale D 7,9471 -25.551 -203 506.630
2022-06-06 2022-06-03 4 Gould Robert J FULC Common Stock M - Exercise D 7,8400 25.551 200 532.181
2022-06-06 2022-06-02 4 Gould Robert J FULC Common Stock S - Sale D 7,9191 -16.689 -132 506.630
2022-06-06 2022-06-02 4 Gould Robert J FULC Common Stock M - Exercise D 7,8400 16.689 131 523.319
2022-05-10 2022-05-06 4 Tourangeau Greg FULC Stock Option (right to buy) A - Award D 8,63 6.500 6.500
2022-05-10 2022-05-06 4 Tourangeau Greg FULC Common Stock A - Award D 3.250 16.202
2022-04-11 2022-04-07 4 Gould Robert J FULC Stock Option (right to buy) M - Exercise D 7,84 -5.631 224.580
2022-04-11 2022-04-07 4 Gould Robert J FULC Common Stock S - Sale D 24,0150 -5.631 -135 506.630
2022-04-11 2022-04-07 4 Gould Robert J FULC Common Stock M - Exercise D 7,8400 5.631 44 512.261
2022-04-05 2022-04-05 4 Gould Robert J FULC Stock Option (right to buy) M - Exercise D 7,84 -52.552 230.211
2022-04-05 2022-04-05 4 Gould Robert J FULC Common Stock S - Sale D 24,2574 -52.552 -1.275 506.630
2022-04-05 2022-04-05 4 Gould Robert J FULC Common Stock M - Exercise D 7,8400 52.552 412 559.182
2022-04-05 2022-04-04 4 Gould Robert J FULC Stock Option (right to buy) M - Exercise D 7,84 -7.235 282.763
2022-04-05 2022-04-04 4 Gould Robert J FULC Common Stock S - Sale D 24,0151 -7.235 -174 506.630
2022-04-05 2022-04-04 4 Gould Robert J FULC Common Stock M - Exercise D 7,8400 7.235 57 513.865
2022-04-05 2022-04-01 4 Gould Robert J FULC Stock Option (right to buy) M - Exercise D 7,84 -34.464 289.998
2022-04-05 2022-04-01 4 Gould Robert J FULC Common Stock S - Sale D 24,0297 -34.464 -828 506.630
2022-04-05 2022-04-01 4 Gould Robert J FULC Common Stock M - Exercise D 7,8400 34.464 270 541.094
2022-03-14 3 Tourangeau Greg FULC Common Stock D 12.952
2022-01-21 2022-01-19 4 Morabito Christopher FULC Stock Option (right to buy) A - Award D 12,69 59.744 59.744
2022-01-21 2022-01-19 4 Oltmans Curtis Gale FULC Stock Option (right to buy) A - Award D 12,69 60.000 60.000
2022-01-21 2022-01-19 4 Dunn Judith FULC Stock Option (right to buy) A - Award D 12,69 140.890 140.890
2022-01-21 2022-01-19 4 Stuart Bryan FULC Stock Option (right to buy) A - Award D 12,69 340.000 340.000
2022-01-21 2022-01-19 4 Thomson Peter G. FULC Stock Option (right to buy) A - Award D 12,69 40.000 40.000
2022-01-10 2022-01-03 4 Rajavelu Esther FULC Stock Option (right to buy) A - Award D 17,82 200.000 200.000
2022-01-10 3 Rajavelu Esther FULC No securities are beneficially owned D 0
2022-01-07 2021-12-17 5 Oltmans Curtis Gale FULC Common Stock G - Gift D -1.088 1.248
2021-12-09 2021-12-08 4 Banks Sonja FULC Stock Option (right to buy) A - Award D 15,73 30.000 30.000
2021-12-09 3 Banks Sonja FULC No securities are beneficially owned D 0
2021-11-12 2021-11-10 4 LEVIN MARK J FULC Common Stock J - Other I -1.000.000 3.962.202
2021-11-12 2021-11-10 4 Third Rock Ventures III, L.P. FULC Common Stock J - Other D -1.000.000 3.962.202
2021-09-24 2021-09-22 4 Third Rock Ventures III, L.P. FULC Common Stock J - Other D -1.000.000 4.962.202
2021-09-24 2021-09-22 4 LEVIN MARK J FULC Common Stock J - Other I -1.000.000 4.962.202
2021-08-12 2021-08-11 4 Stuart Bryan FULC Stock Option (right to buy) M - Exercise D 7,84 -28.000 243.571
2021-08-12 2021-08-11 4 Stuart Bryan FULC Common Stock S - Sale D 23,7500 -28.000 -665 0
2021-08-12 2021-08-11 4 Stuart Bryan FULC Common Stock M - Exercise D 7,8400 28.000 220 28.000
2021-08-12 2021-08-10 4 Stuart Bryan FULC Stock Option (right to buy) M - Exercise D 7,84 -32.000 271.571
2021-08-12 2021-08-10 4 Stuart Bryan FULC Common Stock S - Sale D 17,5000 -32.000 -560 0
2021-08-12 2021-08-10 4 Stuart Bryan FULC Common Stock M - Exercise D 7,8400 32.000 251 32.000
2021-08-12 2021-08-10 4 Moxham Christopher FULC Stock Option (right to buy) M - Exercise D 7,84 -31.071 72.501
2021-08-12 2021-08-10 4 Moxham Christopher FULC Stock Option (right to buy) M - Exercise D 7,84 -20.714 103.572
2021-08-12 2021-08-10 4 Moxham Christopher FULC Common Stockm S - Sale D 18,0000 -31.071 -559 0
2021-08-12 2021-08-10 4 Moxham Christopher FULC Common Stock M - Exercise D 7,8400 31.071 244 31.071
2021-08-12 2021-08-10 4 Moxham Christopher FULC Common Stock S - Sale D 17,0000 -20.714 -352 0
2021-08-12 2021-08-10 4 Moxham Christopher FULC Common Stock M - Exercise D 7,8400 20.714 162 20.714
2021-06-29 2021-06-28 4 Thomson Peter G. FULC Common Stock P - Purchase I 9,0000 2.300 21 2.300
2021-06-29 2021-06-28 4 Oltmans Curtis Gale FULC Common Stock P - Purchase D 9,0100 1.088 10 1.088
2021-06-29 2021-06-28 4 Morabito Christopher FULC Common Stock P - Purchase D 9,1600 1.100 10 1.100
2021-06-29 2021-06-28 4 GERAGHTY JAMES A FULC Common Stock P - Purchase D 9,1600 10.000 92 90.714
2021-06-11 2021-06-09 4 Collins James J. FULC Stock Option (right to buy) A - Award D 8,85 15.000 15.000
2021-06-11 2021-06-09 4 GERAGHTY JAMES A FULC Stock Option (right to buy) A - Award D 8,85 15.000 15.000
2021-06-11 2021-06-09 4 LEVIN MARK J FULC Stock Option (right to buy) A - Award D 8,85 15.000 15.000
2021-06-11 2021-06-09 4 Ezekowitz Alan FULC Stock Option (right to buy) A - Award D 8,85 15.000 15.000
2021-06-11 2021-06-09 4 Dorton Katina FULC Stock Option (right to buy) A - Award D 8,85 15.000 15.000
2021-06-11 2021-06-09 4 Haviland Kate FULC Stock Option (right to buy) A - Award D 8,85 15.000 15.000
2021-05-12 2021-05-10 4 Morabito Christopher FULC Stock Option (right to buy) A - Award D 10,01 163.000 163.000
2021-05-12 3 Morabito Christopher FULC No securities are beneficially owned D 0
2021-04-02 2021-04-01 4 Dunn Judith FULC Stock Option (right to buy) A - Award D 12,00 215.000 215.000
2021-04-02 2021-03-31 4 Stuart Bryan FULC Stock Option (right to buy) A - Award D 11,78 350.000 350.000
2021-04-02 3 Dunn Judith FULC No securities are beneficially owned D 0
2021-03-17 2021-03-16 4 Gould Robert J FULC Common Stock S - Sale D 12,4279 -789 -10 506.630
2021-03-17 2021-03-15 4 Gould Robert J FULC Common Stock S - Sale D 12,1347 -9.211 -112 507.419
2021-02-24 2021-02-22 4 Thomson Peter G. FULC Stock Option (right to buy) M - Exercise D 7,84 -5.000 50.471
2021-02-24 2021-02-22 4 Thomson Peter G. FULC Common Stock S - Sale D 14,7163 -5.000 -74 15.212
2021-02-24 2021-02-22 4 Thomson Peter G. FULC Common Stock M - Exercise D 7,8400 5.000 39 20.212
2021-02-18 2021-02-16 4 Gould Robert J FULC Common Stock S - Sale D 14,5649 -1.673 -24 516.630
2021-02-18 2021-02-16 4 Gould Robert J FULC Common Stock S - Sale D 14,1899 -6.542 -93 518.303
2021-02-10 2021-02-08 4 Moxham Christopher FULC Stock Option (right to buy) A - Award D 12,60 100.000 100.000
2021-02-10 3 Moxham Christopher FULC No securities are beneficially owned D 0
2021-02-04 2021-02-02 4 Gould Robert J FULC Stock Option (right to buy) A - Award D 11,33 269.390 269.390
2021-01-27 2021-01-25 4 Thomson Peter G. FULC Stock Option (right to buy) A - Award D 13,09 40.000 40.000
2021-01-27 2021-01-25 4 Stuart Bryan FULC Stock Option (right to buy) A - Award D 13,09 134.376 134.376
2021-01-25 2021-01-21 4 Thomson Peter G. FULC Common Stock S - Sale D 14,0000 -6.607 -92 15.212
2021-01-22 2021-01-20 4 Gould Robert J FULC Common Stock S - Sale D 12,0826 -10.000 -121 524.845
2020-12-07 2020-12-03 4 Oltmans Curtis Gale FULC Stock Option (right to buy) A - Award D 11,82 153.600 153.600
2020-12-07 2020-12-03 4 Ezekowitz Alan FULC Stock Option (right to buy) A - Award D 11,82 15.000 15.000
2020-12-07 3 Oltmans Curtis Gale FULC No securities are beneficially owned D 0
2020-09-14 2020-09-14 4 Wallace Owen B. FULC Stock Option (right to buy) M - Exercise D 7,84 -6.350 75.592
2020-09-14 2020-09-14 4 Wallace Owen B. FULC Common Stock M - Exercise D 7,8400 6.350 50 133.438
2020-07-09 2020-07-08 4 Wallace Owen B. FULC Stock Option (right to buy) M - Exercise D 7,84 -2.951 81.942
2020-07-09 2020-07-08 4 Wallace Owen B. FULC Common Stock S - Sale D 20,0000 -2.951 -59 127.088
2020-07-09 2020-07-08 4 Wallace Owen B. FULC Common Stock M - Exercise D 7,8400 2.951 23 130.039
2020-07-09 2020-07-08 4 Gould Robert J FULC Common Stock S - Sale D 20,0000 -2.500 -50 534.845
2020-07-02 2020-07-01 4 Cadavid Diego FULC Common Stock S - Sale D 18,3000 -1.071 -20 65.714
2020-07-01 2020-06-30 4 Wallace Owen B. FULC Stock Option (right to buy) M - Exercise D 7,84 -141 84.893
2020-07-01 2020-06-30 4 Wallace Owen B. FULC Common Stock S - Sale D 20,0000 -141 -3 127.088
2020-07-01 2020-06-30 4 Wallace Owen B. FULC Common Stock M - Exercise D 7,8400 141 1 127.229
2020-06-26 2020-06-25 4 Gould Robert J FULC Common Stock S - Sale D 20,7968 -2.500 -52 537.345
2020-06-26 2020-06-25 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4,83 -1.459 12.277
2020-06-26 2020-06-25 4 Cadavid Diego FULC Common Stock S - Sale D 22,0000 -1.459 -32 66.785
2020-06-26 2020-06-25 4 Cadavid Diego FULC Common Stock M - Exercise D 4,8300 1.459 7 68.244
2020-06-15 2020-06-11 4 Haviland Kate FULC Stock Option (right to buy) A - Award D 17,63 9.285 9.285
2020-06-15 2020-06-11 4 Collins James J. FULC Stock Option (right to buy) A - Award D 17,63 9.285 9.285
2020-06-15 2020-06-11 4 Ezekowitz Alan FULC Stock Option (right to buy) A - Award D 17,63 9.285 9.285
2020-06-15 2020-06-11 4 GERAGHTY JAMES A FULC Stock Option (right to buy) A - Award D 17,63 9.285 9.285
2020-06-15 2020-06-11 4 LEVIN MARK J FULC Stock Option (right to buy) A - Award D 17,63 9.285 9.285
2020-06-12 2020-06-10 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4,83 -401 13.736
2020-06-12 2020-06-10 4 Cadavid Diego FULC Common Stock S - Sale D 22,0000 -401 -9 66.785
2020-06-12 2020-06-10 4 Cadavid Diego FULC Common Stock M - Exercise D 4,8300 401 2 67.186
2020-06-10 2020-06-09 4 Gould Robert J FULC Common Stock S - Sale D 20,0000 -156 -3 539.845
2020-06-09 2020-06-05 4 Gould Robert J FULC Common Stock S - Sale D 20,1722 -3.433 -69 540.001
2020-06-08 2020-06-05 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4,83 -451 14.137
2020-06-08 2020-06-05 4 Cadavid Diego FULC Common Stock S - Sale D 20,1791 -451 -9 66.785
2020-06-08 2020-06-05 4 Cadavid Diego FULC Common Stock M - Exercise D 4,8300 451 2 67.236
2020-06-08 2020-06-04 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4,83 -226 14.588
2020-06-08 2020-06-04 4 Cadavid Diego FULC Common Stock S - Sale D 20,0498 -226 -5 66.785
2020-06-08 2020-06-04 4 Cadavid Diego FULC Common Stock M - Exercise D 4,8300 226 1 67.011
2020-06-05 2020-06-04 4 Gould Robert J FULC Common Stock S - Sale D 20,0446 -1.300 -26 543.434
2020-06-05 2020-06-03 4 Gould Robert J FULC Common Stock S - Sale D 20,1283 -1.500 -30 544.734
2020-06-04 2020-06-03 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4,83 -338 14.814
2020-06-04 2020-06-03 4 Cadavid Diego FULC Common Stock S - Sale D 20,1763 -338 -7 66.785
2020-06-04 2020-06-03 4 Cadavid Diego FULC Common Stock M - Exercise D 4,8300 338 2 67.123
2020-06-04 2020-06-02 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4,83 -45 15.152
2020-06-04 2020-06-02 4 Cadavid Diego FULC Common Stock S - Sale D 20,0000 -45 -1 66.785
2020-06-04 2020-06-02 4 Cadavid Diego FULC Common Stock M - Exercise D 4,8300 45 0 66.830
2020-06-03 2020-06-02 4 Gould Robert J FULC Common Stock S - Sale D 20,0000 -2.797 -56 546.234
2020-06-03 2020-06-01 4 Gould Robert J FULC Common Stock S - Sale D 20,0000 -5 -0 549.031
2020-06-01 2020-05-29 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4,83 -200 15.197
2020-06-01 2020-05-29 4 Cadavid Diego FULC Common Stock S - Sale D 20,0350 -200 -4 66.785
2020-06-01 2020-05-29 4 Cadavid Diego FULC Common Stock M - Exercise D 4,8300 200 1 66.985
2020-06-01 2020-05-28 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4,83 -600 15.397
2020-06-01 2020-05-28 4 Cadavid Diego FULC Common Stock S - Sale D 20,0000 -600 -12 66.785
2020-06-01 2020-05-28 4 Cadavid Diego FULC Common Stock M - Exercise D 4,8300 600 3 67.385
2020-06-01 2020-05-28 4 Wallace Owen B. FULC Stock Option (right to buy) M - Exercise D 7,84 -2.232 85.034
2020-06-01 2020-05-28 4 Wallace Owen B. FULC Common Stock S - Sale D 20,0000 -2.232 -45 127.088
2020-06-01 2020-05-28 4 Wallace Owen B. FULC Common Stock M - Exercise D 7,8400 2.232 17 129.320
2020-06-01 2020-05-29 4 Gould Robert J FULC Common Stock S - Sale D 20,0797 -1.390 -28 549.036
2020-06-01 2020-05-28 4 Gould Robert J FULC Common Stock S - Sale D 20,0058 -1.919 -38 550.426
2020-05-29 2020-05-27 4 Wallace Owen B. FULC Stock Option (right to buy) M - Exercise D 7,84 -448 87.266
2020-05-29 2020-05-27 4 Wallace Owen B. FULC Common Stock S - Sale D 20,0000 -448 -9 127.088
2020-05-29 2020-05-27 4 Wallace Owen B. FULC Common Stock M - Exercise D 7,8400 448 4 127.536
2020-05-28 2020-05-26 4 Gould Robert J FULC Common Stock S - Sale D 20,0000 -2.500 -50 552.345
2020-05-28 2020-05-26 4 Wallace Owen B. FULC Stock Option (right to buy) M - Exercise D 7,84 -412 87.714
2020-05-28 2020-05-26 4 Wallace Owen B. FULC Common Stock S - Sale D 20,0000 -412 -8 127.088
2020-05-28 2020-05-26 4 Wallace Owen B. FULC Common Stock M - Exercise D 7,8400 412 3 127.500
2020-05-12 2020-05-11 4 Thomson Peter G. FULC Common Stock S - Sale D 16,0000 -7.500 -120 21.071
2020-05-12 2020-05-12 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4,83 -1.860 15.997
2020-05-12 2020-05-12 4 Cadavid Diego FULC Common Stock S - Sale D 18,0000 -1.860 -33 66.785
2020-05-12 2020-05-12 4 Cadavid Diego FULC Common Stock M - Exercise D 4,8300 1.860 9 68.645
2020-03-02 2020-03-02 4 Cadavid Diego FULC Common Stock S - Sale D 18,1255 -315 -6 66.785
2020-03-02 2020-03-02 4 Cadavid Diego FULC Common Stock S - Sale D 17,2567 -1.828 -32 67.100
2020-02-26 2020-02-24 4 Thomson Peter G. FULC Common Stock S - Sale D 18,6120 -250 -5 28.571
2020-02-26 2020-02-24 4 Thomson Peter G. FULC Common Stock S - Sale D 17,4326 -2.102 -37 28.821
2020-02-26 2020-02-24 4 Thomson Peter G. FULC Common Stock S - Sale D 16,1845 -2.648 -43 30.923
2020-02-20 2020-02-19 4 Wallace Owen B. FULC Stock Option (right to buy) M - Exercise D 7,84 -6.088 88.126
2020-02-20 2020-02-19 4 Wallace Owen B. FULC Common Stock S - Sale D 20,0000 -6.088 -122 127.088
2020-02-20 2020-02-19 4 Wallace Owen B. FULC Common Stock M - Exercise D 7,8400 6.088 48 133.176
2020-02-20 2020-02-19 4 Gould Robert J FULC Common Stock S - Sale D 20,0000 -2.500 -50 554.845
2020-02-05 2020-02-03 4 Cadavid Diego FULC Common Stock S - Sale D 17,3317 -2.143 -37 68.928
2020-01-27 2020-01-23 4 Wallace Owen B. FULC Stock Option (right to buy) A - Award D 16,87 58.900 58.900
2020-01-27 2020-01-23 4 Gould Robert J FULC Stock Option (right to buy) A - Award D 16,87 200.000 200.000
2020-01-27 2020-01-23 4 Thomson Peter G. FULC Stock Option (right to buy) A - Award D 16,87 33.100 33.100
2020-01-27 2020-01-23 4 Thomson Peter G. FULC Common Stock S - Sale D 18,0539 -262 -5 33.571
2020-01-27 2020-01-23 4 Thomson Peter G. FULC Common Stock S - Sale D 17,1743 -4.738 -81 33.833
2020-01-27 2020-01-23 4 Cadavid Diego FULC Stock Option (right to buy) A - Award D 16,87 55.440 55.440
2020-01-27 2020-01-23 4 Stuart Bryan FULC Stock Option (right to buy) A - Award D 16,87 105.000 105.000
2020-01-06 3 Dorton Katina FULC No securities are beneficially owned D 0
2020-01-06 2020-01-02 4 Dorton Katina FULC Stock Option (right to buy) A - Award D 15,86 18.571 18.571
2019-07-24 2019-07-22 4 GLAXOSMITHKLINE PLC FULC Series B Preferred Stock C - Conversion I -12.500.000 0
2019-07-24 2019-07-22 4 GLAXOSMITHKLINE PLC FULC Common Stock C - Conversion I 1.785.714 1.785.714
2019-07-23 2019-07-22 4 Sanofi Through its wholly-owned subsidiary, Aventis Inc. FULC Series B Preferred Stock (par value $0.001) C - Conversion I 0,00 -3.250.000 0
2019-07-23 2019-07-22 4 Sanofi Through its wholly-owned subsidiary, Aventis Inc. FULC Common Stock (par value $0.001) P - Purchase I 16,0000 93.750 1.500 558.035
2019-07-23 2019-07-22 4 Sanofi Through its wholly-owned subsidiary, Aventis Inc. FULC Common Stock (par value $0.001) C - Conversion I 464.285 464.285
2019-07-22 2019-07-22 4 Section 32 Fund 2, LP FULC Series B Preferred Stock C - Conversion D -3.250.000 0
2019-07-22 2019-07-22 4 Section 32 Fund 2, LP FULC Common Stock C - Conversion D 464.285 464.285
2019-07-22 2019-07-22 4 LEVIN MARK J By fund FULC Series A Preferred Stock C - Conversion I -39.166.667 0
2019-07-22 2019-07-22 4 LEVIN MARK J By fund FULC Common Stock P - Purchase I 16,0000 81.250 1.300 5.962.202
2019-07-22 2019-07-22 4 LEVIN MARK J By fund FULC Common Stock C - Conversion I 5.595.238 5.880.952
2019-07-22 2019-07-22 4 Casdin Capital, LLC FULC Series B Preferred Stock C - Conversion I -3.250.000 0
2019-07-22 2019-07-22 4 Casdin Capital, LLC FULC Common Stock P - Purchase I 14,4998 5.000 72 604.285
2019-07-22 2019-07-22 4 Casdin Capital, LLC FULC Common Stock P - Purchase I 14,4996 10.000 145 599.285
2019-07-22 2019-07-22 4 Casdin Capital, LLC FULC Common Stock P - Purchase I 16,0000 125.000 2.000 589.285
2019-07-22 2019-07-22 4 Casdin Capital, LLC FULC Common Stock C - Conversion I 464.285 464.285
2019-07-22 2019-07-22 4 6 Dimensions Capital, L.P. FULC Series B Preferred Stock C - Conversion D -3.087.500 0
2019-07-22 2019-07-22 4 6 Dimensions Capital, L.P. FULC Common Stock P - Purchase D 16,0000 118.750 1.900 559.821
2019-07-22 2019-07-22 4 6 Dimensions Capital, L.P. FULC Common Stock C - Conversion D 441.071 441.071
2019-07-22 2019-07-22 4 Third Rock Ventures III, L.P. FULC Series A Preferred Stock C - Conversion D 0 0
2019-07-22 2019-07-22 4 Third Rock Ventures III, L.P. FULC Series A Preferred Stock C - Conversion D -39.166.667 0
2019-07-22 2019-07-22 4 Third Rock Ventures III, L.P. FULC Common Stock P - Purchase D 16,0000 81.250 1.300 5.962.202
2019-07-22 2019-07-22 4 Third Rock Ventures III, L.P. FULC Common Stock C - Conversion D 5.595.238 5.880.952
2019-07-22 2019-07-22 4 Third Rock Ventures IV, L.P. FULC Series A Preferred Stock C - Conversion D -15.833.333 0
2019-07-22 2019-07-22 4 Third Rock Ventures IV, L.P. FULC Common Stock P - Purchase D 16,0000 81.250 1.300 2.343.154
2019-07-22 2019-07-22 4 Third Rock Ventures IV, L.P. FULC Common Stock C - Conversion D 2.261.904 2.261.904
2019-07-18 2019-07-18 4 Thomson Peter G. FULC Stock Option (right to buy) A - Award D 16,00 7.078 7.078
2019-07-18 2019-07-18 4 Stuart Bryan FULC Stock Option (right to buy) A - Award D 16,00 28.571 28.571
2019-07-18 2019-07-18 4 Cadavid Diego FULC Stock Option (right to buy) A - Award D 16,00 12.784 12.784
2019-07-18 2019-07-18 4 Gould Robert J FULC Stock Option (right to buy) A - Award D 16,00 107.142 107.142
2019-07-18 2019-07-18 4 Haviland Kate FULC Stock Option (right to buy) A - Award D 16,00 9.285 9.285
2019-07-18 2019-07-18 4 Ezekowitz Alan FULC Stock Option (right to buy) A - Award D 16,00 5.714 5.714
2019-07-18 2019-07-18 4 GERAGHTY JAMES A FULC Stock Option (right to buy) A - Award D 16,00 9.285 9.285
2019-07-18 2019-07-18 4 Collins James J. FULC Stock Option (right to buy) A - Award D 16,00 5.714 5.714
2019-07-18 2019-07-18 4 Wallace Owen B. FULC Stock Option (right to buy) A - Award D 16,00 44.493 44.493
2019-07-17 3 GERAGHTY JAMES A FULC Common Stock D 161.428
2019-07-17 3 GERAGHTY JAMES A FULC Common Stock D 161.428
2019-07-17 3 GERAGHTY JAMES A FULC Common Stock D 161.428
2019-07-17 3 Collins James J. FULC Common Stock D 47.142
2019-07-17 3 Collins James J. FULC Common Stock D 47.142
2019-07-17 3 Collins James J. FULC Common Stock D 47.142
2019-07-17 3 Wallace Owen B. FULC Common Stock D 254.176
2019-07-17 3 Wallace Owen B. FULC Common Stock D 254.176
2019-07-17 3 Wallace Owen B. FULC Common Stock D 254.176
2019-07-17 3 Gould Robert J FULC Common Stock D 1.114.690
2019-07-17 3 Gould Robert J FULC Common Stock D 1.114.690
2019-07-17 3 Gould Robert J FULC Common Stock D 1.114.690
2019-07-17 3 Thomson Peter G. FULC Common Stock D 77.142
2019-07-17 3 Thomson Peter G. FULC Common Stock D 77.142
2019-07-17 3 Thomson Peter G. FULC Common Stock D 77.142
2019-07-17 3 Ezekowitz Alan FULC Common Stock D 57.854
2019-07-17 3 Ezekowitz Alan FULC Common Stock D 57.854
2019-07-17 3 Ezekowitz Alan FULC Common Stock D 57.854
2019-07-17 3 Cadavid Diego FULC Common Stock D 142.142
2019-07-17 3 Cadavid Diego FULC Common Stock D 142.142
2019-07-17 3 Cadavid Diego FULC Common Stock D 142.142
2019-07-17 3 LEVIN MARK J FULC Common Stock I 571.428
2019-07-17 3 LEVIN MARK J FULC Common Stock I 571.428
2019-07-17 3 LEVIN MARK J FULC Common Stock I 571.428
2019-07-17 3 TEPPER ROBERT I FULC Common Stock I 571.428
2019-07-17 3 TEPPER ROBERT I FULC Common Stock I 571.428
2019-07-17 3 TEPPER ROBERT I FULC Common Stock I 571.428
2019-07-17 3 TEPPER ROBERT I FULC Common Stock I 571.428
2019-07-17 3 TEPPER ROBERT I FULC Common Stock I 571.428
2019-07-17 3 TEPPER ROBERT I FULC Common Stock I 571.428
2019-07-17 3 TEPPER ROBERT I FULC Common Stock I 571.428
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista